Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-08
1999-07-27
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514278, 546 17, 546154, 546158, 546164, A61K 3147, C07D40104
Patent
active
059290870
ABSTRACT:
Compounds of formula I or formula II: ##STR1## wherein R, J, and Q have any of the values defined in the specification, and their pharmaceutically acceptable salts and related radiopharmaceuticals, have anticholinergic activity, and are useful for modulating cholinergic function in mammals. Also disclosed are pharmaceutical compositions, processes for preparing compounds of formula (I) or (II) and intermediates.
REFERENCES:
patent: 5338852 (1994-08-01), Efange et al.
patent: 5358712 (1994-10-01), Efange et al.
patent: 5457207 (1995-10-01), Efange et al.
patent: 5554752 (1996-09-01), Efange
Binkley, P.F., et al., "Parasympathetic Withdrawal is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure", JACC, vol. 18, No. 2, 464-472, (Aug. 1991).
Brittain, R.T., et al., "The Neuromuscular Blocking Action of 2-(4-Phenylpiperidino) Cycl9ohexanol (AH 5183)", European Journal of Pharmacology 8, 93-99, (1969).
Buccafusco, J.J., et al., "The Effect of the Acetylcholine Transport Blocker Vesamicol on Central Cholinergic Pressor Neurons", SYNAPSE 8, 301-306, (1991).
Capece, M.L., et al., "Vesicular Acetylcholine Transport Inhibitor Suppresses REM Sleep", NeuroReport, vol. 8, No. 2, 481-484, (Jan. 20, 1997).
Erickson, J.D., et al., "Functional Identification of a Vesicular Acetylcholine Transporter and Its Expression from a "Cholinergic" Gene Locus", The Journal of Biological Chemistry, vol. 269, No. 35, 21929-21932, (Sep. 2, 1994).
Higgins, C.B., et al., "Parasympathetic Control of the Heart", Pharmacological Reviews, vol. 25, No. 1, 119-155, (1973).
Leao, R.M., et al., "Inhibition of Potassium-stimulated Acetylcholine Release From Rat Brain Cortical Slices by Two High-Affinity Analogs of Vesamicol", Brain Research 703, 86-92, (1995).
Marien, M.R., et al., "Suppression of In Vivo Neostriatal Acetylcholine Release by Vesamicol: Evidence for a Functional Role of Vesamicol Receptors in Brain", Journal of Neurochemistry, vol. 57, No. 6, 1878-1883, (1991).
Marshall, I.G., "Studies on the Blocking Action of 2-(4-Phenyl Piperidino) Cyclohexanol (AH5183)", Br. J. Pharmac, 38, 503-516, (1970).
Salin-Pascual, R.J., et al., "Vesamicol, an Acetylcholine Uptake Blocker in Presynaptic Vesicles, Suppresses Rapid Eye Movement (REM) Sleep in the Rat", Psychopharmacology 121, 485-487, (1995).
Searl, T., et al., "Acetylcholine Recycling and Release at Rat Motor Nerve Terminals Studied Using (-)-Vesamicol and Troxpyrrolium", Journal of Physiology, 444, 99-116, (1991).
Usdin, T.B., et al., "Molecular Biology of the Vesicular ACh Transporter", TINS vol. 18, No. 5, 218-224, (1995).
Varoqui, H., et al., "Cloning and Expression of the Vesamicol Binding Protein from the Marine Ray Torpedo", FEBS Letters 342 (1994) 97-102, 97-102, (1994). as a New PET Tracer of Cholinergic Neurons of the Heart", Nucl. Med. Biol., vol. 21, 189-195, (1994).
Parsons, SM et al. Progress in Brain Research, 98, pp. 175-181, 1993.
Rogers GA et al. J. Med. Chem. 32, pp. 1217-1230, 1989.
Efange S. Mbua Ngale
Parsons Stanley M.
Huang Evelyn Mei
Regents of the University of Minnesota
LandOfFree
Decahydroquinoline-based anti-cholinergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Decahydroquinoline-based anti-cholinergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Decahydroquinoline-based anti-cholinergic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-879036